8-K: USANA Health Sciences Reports Mixed Q1 2025 Results, Reaffirms Full-Year Outlook

USANA Health Sciences announced its Q1 2025 financial results, showing revenue growth but a decrease in net earnings, while reiterating its full-year outlook.

Summary

• USANA Health Sciences reported net sales of $250 million for Q1 2025, a 10% increase compared to $228 million in Q1 2024.
• Net earnings decreased to $9.4 million from $16.5 million year-over-year.
• Diluted EPS was $0.49, down from $0.86 in the prior year.
• Adjusted diluted EPS was $0.73, compared to $0.86 in the same period last year.
• Adjusted EBITDA decreased to $30 million from $33 million.
• The company's direct selling active customers decreased to 459,000 from 494,000.
• Hiya, the direct-to-consumer business, reported 224,000 active monthly subscribers.
• USANA is reiterating its fiscal year 2025 outlook, projecting net sales between $920 million and $1.0 billion.
• The company expects net earnings to be between $29 million and $41 million, with diluted EPS between $1.50 and $2.20.
• Adjusted diluted EPS is projected to be between $2.35 and $3.00, and adjusted EBITDA between $107 million and $123 million.
• The company repurchased 399,000 shares for $12 million during the quarter, with $49 million remaining under the share repurchase authorization.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue increased, earnings decreased. The company is reiterating its full-year outlook, which provides some reassurance, but concerns about global economic conditions and tariffs remain.

Positives

• Net sales increased by 10% year-over-year, reaching $250 million.
• Hiya's strong performance contributed $37 million in net sales and 224,000 active monthly subscribers.
• The company generated $15 million in operating cash flow.
• USANA is reiterating its full-year 2025 outlook, indicating confidence in future performance.
• The direct selling business saw net sales and active customers grow modestly on a sequential basis for the second consecutive quarter.

Negatives

• Net earnings decreased by 43% year-over-year, falling to $9.4 million.
• Diluted EPS decreased by 43% year-over-year, reaching $0.49.
• Adjusted EBITDA decreased by 10% year-over-year, reaching $30 million.
• Direct selling active customers decreased to 459,000 from 494,000 year-over-year.
• The effective tax rate increased to 44.5% from 39.0% in the comparable period of 2024.

Risks

• Global economic conditions and consumer sentiment remain uncertain.
• Volatility in international trade and tariffs could impact the company's performance.
• Potential negative effects of deteriorating foreign and/or trade relations between or among the United States, China and other key markets.
• The impact of potential trade policies and tariffs remains highly uncertain.
• The company faces risks associated with reliance upon its network of independent Associates.
• The company faces risks associated with governmental regulation of its products, manufacturing and direct selling business model in the United States, China and other key markets.

Future Outlook

USANA is reiterating its fiscal year 2025 outlook, projecting net sales between $920 million and $1.0 billion, net earnings between $29 million and $41 million, diluted EPS between $1.50 and $2.20, adjusted diluted EPS between $2.35 and $3.00, and adjusted EBITDA between $107 million and $123 million.

Management Comments

• Jim Brown, President and Chief Executive Officer, stated that USANA is off to a solid start to the year and is seeing encouraging signs in the direct sales business.
• Doug Hekking, Chief Financial Officer, noted that first quarter operating results were in line with internal expectations and reflected solid contributions from the direct selling business and strong top line growth from Hiya.

Industry Context

The direct selling industry is facing challenges related to changing consumer preferences and increased competition. USANA's acquisition of Hiya reflects a strategy to diversify its business model and reach new customer demographics in the children's health and wellness market. The company's focus on product innovation and associate engagement is aimed at driving growth in a competitive environment.

Comparison to Industry Standards

• Nu Skin Enterprises, another direct selling company, reported similar challenges in active customer counts, indicating a broader trend in the industry.
• Herbalife Nutrition, a major competitor, has also been focusing on adapting its business model to changing consumer preferences, including increased online sales and digital marketing.
• The growth of Hiya is comparable to other direct-to-consumer health and wellness brands that have seen success in targeting specific demographics with specialized products.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net earnings and EPS.
• Associates will be impacted by changes to the incentive program and the focus on customer growth.
• Customers will benefit from new product launches and improved existing products.
• Employees will be involved in the execution of the company's strategic initiatives.

Next Steps

• USANA's management team will hold a conference call and webcast on April 23, 2025, to discuss the results.
• The company will continue to focus on new product launches, associate incentive programs, and brand messaging to drive growth in the direct selling business.
• Hiya will continue to focus on product launches, strategic partnerships, and channel expansion.
• The company will continue to monitor and assess the evolving global trade environment and potential tariff impacts.

Key Dates

Keywords

USANA, financial results, direct selling, Hiya, net sales, EBITDA, EPS, outlook, active customers, share repurchase